It showed about 15% weight loss in trials, with very promising results for reducing liver fat in people with fatty liver disease
Specific supplements that practitioners commonly recommend alongside GLP-1 microdosing for autoimmune conditions include vitamin D (immune modulator), omega-3 fish oil (anti-inflammatory), and curcumin (NF-kB inhibitor through a complementary pathway)
For someone starting at 250 pounds, that represents approximately 44 pounds
For patients with obesity-related comorbidities such as hypertension, dyslipidaemia, or fatty liver disease these combined effects could represent a clinically meaningful advance if confirmed in Phase 3 data
Ozempic rose from a 10 th place ranking among the 10 top-selling Part D drugs in 2021, with gross spending of $2.6 billion, to 6 th place in 2022, with spending of $4.6 billion (Figure 2)